Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$43.42 - $57.37 $16,977 - $22,431
-391 Reduced 2.35%
16,260 $784,000
Q4 2022

Feb 14, 2023

SELL
$38.8 - $55.46 $11,407 - $16,305
-294 Reduced 1.74%
16,651 $831,000
Q3 2022

Nov 14, 2022

SELL
$38.15 - $57.1 $73,286 - $109,689
-1,921 Reduced 10.18%
16,945 $666,000
Q2 2022

Aug 15, 2022

SELL
$33.54 - $55.0 $373,266 - $612,095
-11,129 Reduced 37.1%
18,866 $1.04 Million
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $91,571 - $142,227
2,952 Added 10.92%
29,995 $1.09 Million
Q4 2021

Feb 14, 2022

SELL
$41.14 - $56.98 $582,912 - $807,349
-14,169 Reduced 34.38%
27,043 $1.26 Million
Q3 2021

Nov 12, 2021

SELL
$35.31 - $50.56 $227,537 - $325,808
-6,444 Reduced 13.52%
41,212 $2.08 Million
Q2 2021

Aug 13, 2021

SELL
$25.8 - $41.09 $511,691 - $814,937
-19,833 Reduced 29.39%
47,656 $1.96 Million
Q1 2021

May 14, 2021

BUY
$23.55 - $32.4 $54,800 - $75,394
2,327 Added 3.57%
67,489 $1.96 Million
Q4 2020

Feb 08, 2021

BUY
$25.8 - $32.39 $606,016 - $760,808
23,489 Added 56.37%
65,162 $1.84 Million
Q3 2020

Nov 12, 2020

BUY
$27.5 - $39.61 $135,795 - $195,594
4,938 Added 13.44%
41,673 $1.29 Million
Q2 2020

Jul 17, 2020

BUY
$36.1 - $42.56 $1.33 Million - $1.56 Million
36,735 New
36,735 $1.56 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.49B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.